In a new study the vast majority of patients with neurological disorders receive symptom relief from marijuana use.
According to researchers “the purpose of this study was to investigate the quality of life of patients receiving medical cannabis.” One hundred patients receiving medical cannabis were given (a) a socio-demographic and clinical questionnaire, and (b) the SF-36 Health Survey scale for assessing quality of life.
“The majority of our patients who received medical cannabis to treat their neurological disorders (58%) reported decrease in their symptoms (96%), better energy and vitality (68%), ability to perform their professional duties (88%), and an improvement in sleeping and appetite (79% and 71%, respectively) after receiving medical cannabis”, states the study.
The study’s participants “exhibited very few restrictions in activities due to emotional difficulties, a moderate general health status as well as moderate vitality and energy.” Participants, who reported a longer period of receiving medical cannabis, “reported statistically significant more energy and vitality, but also better mental and general health status.”
Furthermore, “the majority of patients have disclosed medical cannabis use to their family members (85%) and enjoyed their support (93%), but they haven’t revealed their medication treatment to their social environment (81%).”
Conducted by researchers at the University of West Attica in Greece, the study is published in the recent issue of the journal Advances in Experimental Medicine and Biology.